Schaffnit Jeffrey R. 4
4 · Iterum Therapeutics plc · Filed May 29, 2018
Insider Transaction Report
Form 4
Schaffnit Jeffrey R.
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-05-24+25,461→ 25,461 totalExercise: $13.00Exp: 2028-05-23→ Ordinary Shares (25,461 underlying) - Award
Stock Option (Right to Buy)
2018-05-24+6,365→ 6,365 totalExercise: $13.00Exp: 2028-05-23→ Ordinary Shares (6,365 underlying)
Footnotes (2)
- [F1]The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of February 19, 2018 (the "Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date.
- [F2]The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of May 24, 2018 (the "Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date.